ÂÜÀòÂÒÂ×

Venkat Ramanan currently serves as Chief Financial Officer at Anthos Therapeutics since 2024, following a previous role in the same position at Turnstone Biologics from 2022 to 2024. From 2016 to 2022, Venkat held various senior finance roles at Seagen, including SVP Finance and VP Finance. Prior experience includes multiple director-level positions at Gilead Sciences from 2007 to 2016, and a board membership at the Indian Institute of Liver and Digestive Sciences from 2014 to 2016. Additionally, Venkat worked at Amgen from 2002 to 2007 as a Senior Manager and Manager in strategic resource planning and business analysis. Earlier in the career, Venkat was a consultant at ZS Associates and a research associate at the University of Wisconsin.